To describe the therapeutic pathways of patients with psoriasis (PSO) and psoriatic arthritis (PsA) before and after treatment with biological therapies in a real-world setting and to determine the relative consumption of health care resources.
Analysis of drug utilization and health care resource consumption in patients with psoriasis and psoriatic arthritis before and after treatment with biological therapies
Rossini, Maurizio;Girolomoni, Giampiero
2018-01-01
Abstract
To describe the therapeutic pathways of patients with psoriasis (PSO) and psoriatic arthritis (PsA) before and after treatment with biological therapies in a real-world setting and to determine the relative consumption of health care resources.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
Analysis of drug utilization.pdf
accesso aperto
Descrizione: Articolo principale
Tipologia:
Altro materiale allegato
Licenza:
Creative commons
Dimensione
633.3 kB
Formato
Adobe PDF
|
633.3 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.